NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy ...
A large population-based cohort study from Sweden has found that prenatal exposure to antibiotics was associated with an ...
Maternal use of antibiotics during pregnancy may raise the risk of babies developing Group B Streptococcus (GBS) disease -- a ...
Nexsen Biotech Pty Ltd. developed a rapid diagnostic test for Group B Streptococcus, a highly prevalent and potentially fatal bacteria that is the single largest maternal health problem faced by ...
Beautiful newborn baby boy in the neonatal intensive care unit sleeping This review provides a concise overview of the prevention of Group B Streptococcus in the newborn.
A new January 2026 study found that use of antibiotics during pregnancy may raise the risk of babies developing Group B ...